{"id":72,"date":"2019-01-31T17:19:58","date_gmt":"2019-01-31T08:19:58","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol-test\/en\/?page_id=72"},"modified":"2019-02-01T13:24:42","modified_gmt":"2019-02-01T04:24:42","slug":"achievements2008","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/achievements\/achievements2008\/","title":{"rendered":"Before 2008"},"content":{"rendered":"

English-language papers(\u203bcorresponding author)<\/strong><\/h4>\n
    \n
  1. Dudley AC., Shih SC., Cliffe AR.,\u00a0Hida K.<\/strong><\/u>\u00a0and Klagsbrun M.: Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine.\u00a0Br J Cancer<\/em><\/strong>, 99(1), 118-125, 2008.<\/li>\n
  2. Hata H., Kitamura T., Higashino F.,\u00a0Hida K.<\/strong><\/u>, Yoshida K., Ohiro Y., Totsuka Y., Kitagawa Y. and Shindoh M.: Expression of E1AF, and ets-oncogene transcription factor, expression highly correlates with malignant phenotype of malignant melanoma through upregulating membrane-type-1 matrix metalloproteinase gene.\u00a0Oncol Rep,<\/em><\/strong>\u00a019(5), 1093-1098, 2008<\/li>\n
  3. *Hida K<\/u>., Hida Y. and Shindoh M.: Understanding Abnormality of Tumor Endothelial Cells to Develop Ideal Anti-angiogenic Therapies.\u00a0Cancer Sci<\/em>.<\/strong>\u00a099 (3), 459-466, 2008<\/li>\n
  4. Amin D.,\u00a0Hida K.,<\/strong><\/u>\u00a0Bielenberg D. and Klagsbrun M.:Expression of epidermal growth factor (EGF) receptor but not ErbB3 in Tumor endothelial cells coincides with responsiveness to EGF and sensitivity to EGFR kinase inhibitors.\u00a0Cancer Res.,<\/em><\/strong>\u00a066 (4), 2173-2180, 2006<\/li>\n
  5. *Hida K.<\/strong><\/u>. and Klgsbrun M.: A new perspective on tumor endothelial cells; Unexpected Chromosome and centrosome abnormalities.\u00a0Cancer Res,<\/em><\/strong>\u00a065 (7), 1-4, 2005<\/li>\n
  6. Hida K<\/u>., Hida Y., Amin D., Flint A., Panigrahy D., Morton C. and Klagsbrun M.: Tumor-associated endothelial cells with cytogenetic abnormalities.\u00a0Cancer Res.,<\/em><\/strong>\u00a064(22), 8249-8255, 2004\u3000\u3014PDF\u3015<\/a><\/li>\n
  7. Shindoh M., Adachi M., Higashino F., Yasuda M.,\u00a0Hida K.,<\/strong><\/u>\u00a0Nishioka K., Takayama S., Reed J.C., Imai K., Totsuka Y. and Kohgo T.:BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma.\u00a0Oral Oncol<\/em><\/strong>, 36(5), 444-449, 2000<\/li>\n
  8. Hanzawa M., Shindoh M., Higashino F., Yasuda,M.,\u00a0Hida K.,<\/strong><\/u>\u00a0Kohgo T., Nakamura M., Notani K., Totsuka Y., Yoshida K. and Fujinaga K.: Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma (SCC) cell invasion by activating matrix metalloproteinase genes.\u00a0Carcinogenesis<\/em><\/strong>, 21(6), 1079-1085, 2000<\/li>\n
  9. Hida K.,<\/strong><\/u>\u00a0Shindoh M., Yoshida K., Yasuda M., Hanzawa M., Funaoka K., Kohgo T., Amemiya A., Totsuka Y. and Fujinaga K.: Antisense E1AF transfection restrains oral cancer invasion by reducing MMPs activities.\u00a0Am J Pathol<\/em><\/strong>, 150, 2125-2132, 1997<\/li>\n
  10. Hida K.<\/strong><\/u>, Shindoh M., Yoshida K., Kudoh A., Funaoka K., Kohgo T., Fujinaga K. and Totsuka Y.: Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinomas.\u00a0Oral Oncol,<\/em><\/strong>\u00a033(6), 426-430, 1997<\/li>\n
  11. Funaoka K., Shindoh M.,Yoshida K.,Hanzawa M.,\u00a0Hida K<\/a>.<\/u>,Nishikata S., Totsuka Y. and Fijinaga K.: Activation of the p21(Waf1\/Cip1) promoter by the ets oncogene family transcription factor E1AF,\u00a0Biochem Biophys Res Commun<\/em><\/strong>, 236(1), 79-82, 1997<\/li>\n
  12. Shindoh M., Higashino F., Kaya M., Yasuda M., Funaoka K., Hanzawa M.,\u00a0Hida K.<\/strong><\/u>, Kohgo T, Amemiya A., Yoshida K. and Fujinaga K.: Correlated expression of matrix metalloproteinases and ets-family transcription factor E1A-F in invasive oral-squamous-cell-carcinoma-derived cell lines.\u00a0Am J Pathol<\/em><\/strong>, 148(3), 693-700, 1996.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    English-language papers(\u203bcorresponding author) Dudley AC., Shih SC., Cliffe AR.,\u00a0Hida K.\u00a0and Klagsbrun M.: Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivit…\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":19,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-72","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/72","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/comments?post=72"}],"version-history":[{"count":2,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/72\/revisions"}],"predecessor-version":[{"id":84,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/72\/revisions\/84"}],"up":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/pages\/19"}],"wp:attachment":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/en\/wp-json\/wp\/v2\/media?parent=72"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}